Genetic and biochemical studies led to the identification of a number of genes involved in the etiology of CMDs and revealed that alterations in post-translational processing of dystroglycan underlie MEB/WWS [9]–[15]. Here, DAG1 is linked to muscular dystrophy-dystroglycanopathy, type A.